GlassScriptPhysician profile
Peter Sfakianos
NPI 1295791465
$1,344.59
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $170 · 2020: $126 · 2021: $618 · 2022: $179 · 2023: $62.51 · 2024: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $252.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $251.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bone Support INC. | $500.00 | 2021 | |
| Stryker Corporation | $179.90 | 2023-2024 | Inspace, Hydroset |
| Pacira Therapeutics, INC. | $172.46 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $62.50 | 2019-2020 | |
| Fidia Pharma USA INC. | $52.98 | 2019-2022 | |
| Horizon Therapeutics Plc | $52.58 | 2022 | |
| Ibsa Pharma INC. | $48.69 | 2021 | |
| Orthofix Medical, INC. | $48.62 | 2022 | |
| Acell, INC. | $33.95 | 2019 | |
| Integra Lifesciences Corporation | $32.09 | 2022 | |
| Depuy Synthes Sales INC. | $30.93 | 2023 | Orthovisc, Monovisc |
| Vertex Pharmaceuticals Incorporated | $26.93 | 2024 | |
| Smith+Nephew, INC. | $21.05 | 2021 | |
| Davol INC. | $20.79 | 2020 | |
| Ethicon US, LLC | $19.53 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $14.35 | 2020 | |
| Medtronic, INC. | $14.12 | 2024 | Swiftset |
| Ferring Pharmaceuticals INC. | $13.12 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Sfakianos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.